rs28364028

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBS1BS2

The NM_004382.5(CRHR1):​c.241+163T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0102 in 152,342 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.010 ( 18 hom., cov: 33)

Consequence

CRHR1
NM_004382.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 1.16

Publications

2 publications found
Variant links:
Genes affected
CRHR1 (HGNC:2357): (corticotropin releasing hormone receptor 1) This gene encodes a G-protein coupled receptor that binds neuropeptides of the corticotropin releasing hormone family that are major regulators of the hypothalamic-pituitary-adrenal pathway. The encoded protein is essential for the activation of signal transduction pathways that regulate diverse physiological processes including stress, reproduction, immune response and obesity. Alternative splicing results in multiple transcript variants. Naturally-occurring readthrough transcription between this gene and upstream GeneID:147081 results in transcripts that encode isoforms that share similarity with the products of this gene. [provided by RefSeq, Aug 2016]
LINC02210-CRHR1 (HGNC:51483): (LINC02210-CRHR1 readthrough) This locus represents naturally occurring readthrough transcription between neighboring genes CRHR1-IT1, CRHR1 intronic transcript 1 (Gene ID: 147081) and CRHR1, corticotropin releasing hormone receptor 1 (Gene ID: 1394) on chromosome 17. The readthrough transcript encodes a protein that shares sequence identity with the product of the CRHR1 gene. [provided by RefSeq, Dec 2016]
MAPT-AS1 (HGNC:43738): (MAPT antisense RNA 1) Implicated in Parkinson's disease. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0102 (1559/152342) while in subpopulation NFE AF = 0.016 (1091/68014). AF 95% confidence interval is 0.0152. There are 18 homozygotes in GnomAd4. There are 722 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1559 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004382.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRHR1
NM_004382.5
MANE Select
c.241+163T>A
intron
N/ANP_004373.2
CRHR1
NM_001145146.2
c.241+163T>A
intron
N/ANP_001138618.1P34998-1
CRHR1
NM_001145148.2
c.241+163T>A
intron
N/ANP_001138620.1P34998-4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CRHR1
ENST00000314537.10
TSL:1 MANE Select
c.241+163T>A
intron
N/AENSP00000326060.6P34998-2
CRHR1
ENST00000398285.7
TSL:1
c.241+163T>A
intron
N/AENSP00000381333.3P34998-1
CRHR1
ENST00000577353.5
TSL:1
c.241+163T>A
intron
N/AENSP00000462016.1P34998-4

Frequencies

GnomAD3 genomes
AF:
0.0103
AC:
1562
AN:
152224
Hom.:
18
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00294
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0133
Gnomad ASJ
AF:
0.00461
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00931
Gnomad FIN
AF:
0.00273
Gnomad MID
AF:
0.0443
Gnomad NFE
AF:
0.0160
Gnomad OTH
AF:
0.0196
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0102
AC:
1559
AN:
152342
Hom.:
18
Cov.:
33
AF XY:
0.00969
AC XY:
722
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00291
AC:
121
AN:
41594
American (AMR)
AF:
0.0133
AC:
203
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00461
AC:
16
AN:
3472
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5184
South Asian (SAS)
AF:
0.00932
AC:
45
AN:
4828
European-Finnish (FIN)
AF:
0.00273
AC:
29
AN:
10618
Middle Eastern (MID)
AF:
0.0408
AC:
12
AN:
294
European-Non Finnish (NFE)
AF:
0.0160
AC:
1091
AN:
68014
Other (OTH)
AF:
0.0194
AC:
41
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
80
160
241
321
401
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00617
Hom.:
0
Bravo
AF:
0.0109
Asia WGS
AF:
0.00260
AC:
9
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
6.4
DANN
Benign
0.68
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28364028; hg19: chr17-43894111; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.